We are live on
!
Find out more
Amneal Pharmaceuticals
AMRX
AMRX
133 hedge funds and large institutions have $356M invested in Amneal Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 38 increasing their positions, 43 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
79% more call options, than puts
Call options by funds: $1.93M | Put options by funds: $1.08M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.4% less ownership
Funds ownership: 68.79% → 67.39% (-1.4%)
5% less funds holding
Funds holding: 140 → 133 (-7)
10% less capital invested
Capital invested by funds: $394M → $356M (-$37.4M)
12% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 43
21% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 29
Holders
133
Holders Change
-7
Holders Change %
-5%
% of All Funds
2.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
38
Reduced
43
Closed
29
Calls
$1.93M
Puts
$1.08M
Net Calls
+$853K
Net Calls Change
+$102K
Top Buyers
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$2.45M |
| 2 |
JP Morgan Chase
New York
|
+$2M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.84M |
| 4 |
Goldman Sachs
New York
|
+$1.7M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$1.47M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.67M |
| 2 |
EP
Eversept Partners
New York
|
-$6.55M |
| 3 |
BlackRock
New York
|
-$4.07M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$1.99M |
| 5 |
Bank of New York Mellon
New York
|
-$989K |
